Preoperative Highflow Nasal Oxygen Application in Cesarean Under General Anesthesia and Its Effects on Newborn.

Cesarean Delivery Affecting Newborn Clinical Trial

Official title:

In the Study; Preoperative Highflow Nasal Oxygen Application in Cesarean Under General Anesthesia and Its Effects on Newborn.

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03903003
• Other study ID #: KIA 2018/506
• Status: Completed
• Phase: N/A
• Start date: January 1, 2019
• Est. completion date: December 31, 2019

Study information

• Verified date: March 2021
• Source: Kocaeli Derince Education and Research Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Preoperative Highflow Nasal Oxygen Application in Cesarean Under General Anesthesia and Its Effects on Newborn.

Description:

Patients who will undergo caesarean section under general anesthesia will be included in the study. In the study; preoxygenation is applied to the caesarean sections under general anesthesia in two ways. Group1 includes preoxygenation masked patients.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 100
• Est. completion date: December 31, 2019
• Est. primary completion date: March 8, 2019
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Female
• Age group: 18 Years to 80 Years

Eligibility

Inclusion Criteria:

• over 18 years old;
• Patients undergoing elective ceserian operation

Exclusion Criteria:

• Patients who refuse to participate in the study;
• Patients under emergency conditions.

Related Conditions & MeSH terms

• Cesarean Delivery Affecting Newborn

Intervention

Device:
• high flow nasal oxygen device (POINT)
With POINT device (peri-operative insufflatory nasal therapy); patients are heated at higher flow and applied to humidified oxygen.
• Face mask
In order to protect the mother from hypoxia, preoxygenation is performed with face mask before induction of anesthesia.

Locations

Country	Name	City	State
Turkey	Kocaeli Derince Education and Research Hospital	Kocaeli

Sponsors (1)

Lead Sponsor	Collaborator
Kocaeli Derince Education and Research Hospital

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	durations of stay	compare the durations of stay in the intensive care unit and in hospital	24 hours